On October 21, Intuitive Surgical fell 8.12% in Regular Trading, trading at $416.14/share, with turnover of $211 million.
The move followed a strong third-quarter report that was outweighed by management narrowing its outlook for global da Vinci procedure growth, now expecting growth to land closer to the midpoint of its 14% to 15% range.
Intuitive Surgical reported adjusted EPS of $3.00 and revenue of $3.049 billion for the quarter, both above market expectations. However, investors focused on procedure trends: US da Vinci procedures rose 10% while procedures outside the US increased 20%. Because the US business accounts for roughly 60% of overall volume and management had previously flagged softer US demand, including a modest effect from the expiration of enhanced Affordable Care Act subsidies, the updated growth framing appears to have reinforced concerns about the durability of volume growth despite the earnings beat.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments